GlobalData's “Pharmaceutical & Healthcare Annual Deals Analysis 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on Partnerships, Licensing Agreements, M&As, Equity/Debt Offerings, Private Equity and Venture Financing transactions registered in the pharmaceutical and healthcare industry in 2010. The report presents detailed comparative data on the number of deals and their value in the past five years categorized into deal types, segments, and geographies. Additionally, the report provides information on the top venture capital and advisory firms in the pharmaceutical and healthcare industry

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about operations to identify potential customers, partners and suppliers. business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Latest Company Developments:

Table Of Contents

1 Table of contents 2
I. 1 List of Data tables 4
I. 2 List of Charts 7

II Pharmaceutical and Healthcare, Global, Merger and Acquisition Deal Summary 9
II. 1 Pharmaceutical and Healthcare, Global, Deals Analysis, 2010 9
II. 1.1 Pharmaceutical and Healthcare, Global, Deals Analysis, 2010 by Quarter 11
II. 2 Pharmaceutical and Healthcare, Global, by Type, Number of Deals and Deal Values, 2010 13
II. 3 Pharmaceutical and Healthcare, Global, Top Deals, 2010 14
II. 4 Pharmaceutical and Healthcare, Top Deals, Global, Summaries, 2010 15
II. 4.1 November artis Completes Acquisition Of Additional 52% Stake In Alcon From Nestle 15
II. 4.2 Sanofi-Aventis To Raise Its Bid For The Acquisition Of Genzyme 15
II. 4.3 November artis Receives Alcon's Board Approval For The Acquisition Of Remaining 23% Stake 15
II. 4.4 Merck Completes The Acquisition Of Millipore 15
II. 4.5 November artis Completes Public Offering Of Senior Notes For US$ 5000m 15
II. 4.6 HCA Refiles Registration Statement For An Initial Public Offering Of US$ 4,600m 16
II. 4.7 BASF Takes Over Cognis From Permira And Goldman Sachs 16
II. 4.8 Astellas Pharma Takes Over OSI Pharmaceuticals 16
II. 4.9 Reckitt Benckiser Completes Acquisition Of SSL International 16
II. 4.10 Carlyle Group Completes Acquisition Of NBTY 16

III Pharmaceutical and Healthcare, Global, Top Deal Makers, 2010 17

IV Pharmaceutical and Healthcare, Global, Deal Summary, by Type 18
IV. 1 Pharmaceutical and Healthcare, Global, Merger and Acquisition, 2010 18
IV. 1.1 Pharmaceutical and Healthcare, Global, Merger and Acquisition, 2010 by Quarter 19
IV. 1.2 Top Merger and Acquisition Deals in 2010 20
IV. 1.3 Pharmaceuticals and Healthcare, Global, Merger and Acquisition Deals, by Therapy Area, 2010 21
IV. 2 Pharmaceutical and Healthcare, Global, Equity Offering Deals, 2010 22
IV. 2.1 Pharmaceutical and Healthcare, Global, Equity Offering Deals, 2010 by Quarter 23
IV. 2.2 Pharmaceutical and Healthcare, Global, IPO Deals, 2010 24
IV. 2.3 Pharmaceutical and Healthcare, Global, Secondary Offerings Deals, 2010 26
IV. 2.4 Pharmaceutical and Healthcare, Global, PIPE Deals, 2010 28
IV. 2.5 Pharmaceutical and Healthcare, Global, Equity Offering Deals, by Therapy Area, 2010 30
IV. 3 Pharmaceutical and Healthcare, Global, Debt Offering Deals, 2010 31
IV. 3.1 Pharmaceutical and Healthcare, World Debt Offerings, 2010 by Quarter 32
IV. 3.2 Pharmaceutical and Healthcare, Global, Public Debt Offerings, 2010 33
IV. 3.3 Pharmaceutical and Healthcare, Global, Private Debt Placements, 2010 34
IV. 3.4 Pharmaceutical and Healthcare, Global, Debt Offering Deals, by Therapy Area, 2010 36
IV. 4 Pharmaceutical and Healthcare, Global, Partnership Deals, 2010 37
IV. 4.1 Pharmaceutical and Healthcare, Global, Partnership Deals, 2010 by Quarter 38
IV. 4.2 Pharmaceutical and Healthcare, Global, Partnership Deals, by Therapy Area, 2010 40
IV. 4.3 Pharmaceutical and Healthcare, Global, Partnership Deals, by Upfront and Milestone Payments and Deal Value (US$m), 2010 41
IV. 4.4 Pharmaceutical and Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$m), 2010 42
IV. 4.5 Pharmaceutical and Healthcare, Global, Partnership Deals, by Phase, Number Of Deals and Deal Value (US$m), 2010 43
IV. 4.6 Pharmaceutical and Healthcare, Global, Partnership Deals, by Phase, by Upfront and Milestone Payments and Deal Values (US$m), 2010 44
IV. 5 Pharmaceutical and Healthcare, Global, Licensing Agreements, 2010 47
IV. 5.1 Pharmaceutical and Healthcare, Global, Licensing Agreements, 2010 by Quarter 48
IV. 5.2 Pharmaceutical and Healthcare, Global, Licensing Agreements, by Therapy Area, 2010 49
IV. 5.3 Pharmaceutical and Healthcare, Global, Licensing Agreements, by Upfront and Milestone Payments and Deal Value (US$m), 2010 50
IV. 5.4 Pharmaceutical and Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$m), 2010 51
IV. 5.5 Pharmaceutical and Healthcare, Global, Licensing Agreements, by Phase, Number Of Deals and Deal Value (US$m), 2010 52
IV. 5.6 Pharmaceutical and Healthcare, Global, Licensing Agreements, by Phase, by Upfront and Milestone Payments and Deal Values (US$m), 2010 53
IV. 6 Pharmaceutical and Healthcare, Global, Private Equity Deals, 2010 56
IV. 6.1 Pharmaceutical and Healthcare, Global, Private Equity Deals, 2010 by Quarter 57
IV. 6.2 Top Private Equity Deals in 2010 58
IV. 6.3 Pharmaceutical and Healthcare, Global, Private Equity Deals, by Therapy Area, 2010 59
IV. 7 Pharmaceutical and Healthcare, Global, Venture Capital Deals, 2010 60
IV. 7.1 Pharmaceutical and Healthcare, Global, Venture Financing Deals, 2010 by Quarter 61
IV. 7.2 Pharmaceutical and Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2010 62
IV. 7.3 Pharmaceutical and Healthcare, Global, Venture Capital, by Therapy Area, 2010 63
IV. 7.4 Pharmaceutical and Healthcare, Global, Top VC Backed Firms, Last One Year 64
IV. 7.5 Pharmaceutical and Healthcare, Global, Top Venture Financing Firms, 2010 65
IV. 7.6 Top Venture Financing Deals in 2010 66

V Pharmaceutical and Healthcare, Global, Deal Summary, By Therapy Area 67
V. 1 Pharmaceuticals and Healthcare, Global, Oncology Deals, 2010 67
V. 1.1 Pharmaceutical and Healthcare, Global, In Vitro Diagnostics Deals, 2010 by Quarter 69
V. 1.2 Oncology - Deals of the Year 70
V. 2 Pharmaceutical and Healthcare, Global, Central Nervous System Deals, 2010 71
V. 2.1 Pharmaceutical and Healthcare, Global, Central Nervous System Deals, 2010 by Quarter 73
V. 2.2 Central Nervous System - Deals of the Year 74
V. 3 Pharmaceutical and Healthcare, Global, Infectious Disease Deals, 2010 75
V. 3.1 Pharmaceutical and Healthcare, Global, Infectious Disease Deals, 2010 by Quarter 76
V. 3.2 Infectious Disease - Deals of the Year 77
V. 4 Pharmaceutical and Healthcare, Global, Immunology Deals, 2010 78
V. 4.1 Pharmaceutical and Healthcare, Global, Immunology Deals, 2010 by Quarter 79
V. 4.2 Immunology - Deals of the Year 80
V. 5 Pharmaceutical and Healthcare, Global, Cardiovascular Deals, 2010 81
V. 5.1 Pharmaceutical and healthcare, Global, Cardiovascular Deals, 2010 by Quarter 82
V. 5.2 Cardiovascular - Deals of the Year 83
V. 6 Pharmaceutical and Healthcare, Global, Metabolic Disorders Deals, 2010 84
V. 6.1 Pharmaceutical and Healthcare, Global, Metabolic Disorders Deals, 2010 by Quarter 85
V. 6.2 Metabolic Disorders - Deals of the Year 86
V. 7 Pharmaceutical and Healthcare, Global, Dermatology Deals, 2010 87
V. 7.1 Pharmaceutical and Healthcare, Global, Dermatology Deals, 2010 by Quarter 89
V. 7.2 Dermatology - Deals of the Year 90

VI Pharmaceutical and Healthcare, Deal Summary, By Geography 91
VI. 1 Pharmaceutical and Healthcare, North America Region, Deals, 2010 91
VI. 1.1 Pharmaceutical and Healthcare, North America Region, Deals, 2010 by Quarter 93
VI. 1.2 North America - Deals of the Year 94
VI. 2 Pharmaceutical and Healthcare, European Region Deals, 2010 95
VI. 2.1 Pharmaceutical and Healthcare, Europe, Deals, 2010 by Quarter 96
VI. 2.2 Europe - Deals of the Year 97
VI. 3 Pharmaceutical and Healthcare, Asia-Pacific Region, Deals, 2010 98
VI. 3.1 Pharmaceutical and Healthcare, Asia-Pacific Region Deals, 2010 by Quarter 99
VI. 3.2 Asia-Pacific - Deals of the Year 100
VI. 4 Pharmaceutical and Healthcare, Rest of the World (ROW) Deals, 2010 101
VI. 4.1 Pharmaceutical and Healthcare, Rest of the World Deals, 2010 by Quarter 102
VI. 4.2 Rest of the World - Deals of the Year 103

VII Pharmaceutical and Healthcare, Global, Top Financial Advisors 104
VII. 1 Pharmaceutical and Healthcare, Global, Top Financial Advisors, Merger and Acquisition, 2010 104
VII. 2 Pharmaceutical and Healthcare, Global, Top Financial Advisors, Equity Offerings, 2010 105

VIII Further Information 106
VIII. 1 Methodology 106
VIII. 2 About GlobalData 106
VIII. 3 Contact Us 107
VIII. 4 Disclosure information 107
VIII. 5 Disclaimer 107

1.1 List of Data tables
Data table 1: Pharmaceutical and Healthcare, Global, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 10
Data table 2: Pharmaceutical and Healthcare, Merger and Acquisition Deal Summary, Global, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 12
Data table 3: Pharmaceutical and Healthcare, Global, Number Of Deals and Deal Values (%), 2010 13
Data table 4: Pharmaceutical and Healthcare, Top Deals, Global, 2010 14
Data table 5: Pharmaceutical and Healthcare, Global, Top Deal Makers, Number of Deals and Deal Value (US$m), 2010 17
Data table 6: Pharmaceutical and Healthcare, Global, Merger and Acquisition, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 18
Data table 7: Pharmaceutical and Healthcare, Global, Merger and Acquisition, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 19
Data table 8: Pharmaceutical and Healthcare, Global, Top Merger and Acquisition Deals, 2010 20
Data table 9: Pharmaceutical and Healthcare, Global, Merger and Acquisition, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), by Therapy Area, 2010 21
Data table 10: Pharmaceutical and Healthcare, Global, Equity Offerings, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 22
Data table 11: Pharmaceutical and Healthcare, Global, Equity Offerings, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 23
Data table 12: Pharmaceutical and Healthcare, Global, IPO Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 24
Data table 13: Pharmaceutical and Healthcare, Global, Top IPOs, 2010 25
Data table 14: Pharmaceutical and Healthcare, Global, Secondary Offerings, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 26
Data table 15: Pharmaceutical and Healthcare, Global, Top Secondary Offerings, 2010 27
Data table 16: Pharmaceutical and Healthcare, Global, PIPEs, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 28
Data table 17: Pharmaceutical and Healthcare, Global, Top PIPE Deals, 2010 29
Data table 18: Pharmaceutical and Healthcare, Global, Equity Offering Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), 2010 30
Data table 19: Pharmaceutical and Healthcare, Global, Debt Offering, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 31
Data table 20: Pharmaceutical and Healthcare, Global, Debt Offering, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 32
Data table 21: Pharmaceutical and Healthcare, Global, Public Debt Offerings, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 33
Data table 22: Pharmaceutical and Healthcare, Global, Top Public Debt Offerings, 2010 33
Data table 23: Pharmaceutical and Healthcare, Global, Private Debt Placements, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 34
Data table 24: Pharmaceutical and Healthcare, Global, Top Private Debt Placements, 2010 35
Data table 25: Pharmaceutical and Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Values (US$m), 2010 36
Data table 26: Pharmaceutical and Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$m), from 2006 to 2010 37
Data table 27: Pharmaceutical and Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 38
Data table 28: Pharmaceutical and Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$m), 2010 40
Data table 29: Pharmaceutical and Healthcare, Partnership Deals, Upfront and Milestone Payment and Deal Values (US$m), 2010 41
Data table 30: Pharmaceutical and Healthcare, Global, Partnership Deals, by Therapy Area, Upfront and Milestone Payment and Deal Values (US$m), 2010 42
Data table 31: Pharmaceutical and Healthcare, Global, Partnership Deals, by Phase, 2010 43
Data table 32: Pharmaceutical and Healthcare, Global, Partnership Deals, by Upfront and Milestone Payment and Deal Values (US$m), 2010 44
Data table 33: Pharmaceutical and Healthcare, Global, Partnerships, Upfront and Milestone Payment and Deal Values (US$m), 2010 45
Data table 34: Pharmaceutical and Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2010 45
Data table 35: Pharmaceutical and Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2010 46
Data table 36: Pharmaceutical and Healthcare, Global, Licensing Agreement Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 47
Data table 37: Pharmaceutical and Healthcare, Global, Licensing Agreement Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 48
Data table 38: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$m), 2010 49
Data table 39: Pharmaceutical and Healthcare, Licensing Agreements, Upfront and Milestone Payments and Deal Values (US$m), 2010 50
Data table 40: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront and Milestone Payments and Deal Values (US$m), 2010 51
Data table 41: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Phase, 2010 52
Data table 42: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Upfront and Milestone Payments and Deal Values (US$m), 2010 53
Data table 43: Pharmaceutical and Healthcare, Global, Partnerships, Upfront and Milestone Payment and Deal Values (US$m), 2010 54
Data table 44: Pharmaceutical and Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2010 54
Data table 45: Pharmaceutical and Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2010 55
Data table 46: Pharmaceutical and Healthcare, Global, Private Equity, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 56
Data table 47: Pharmaceutical and Healthcare, Global, Private Equity, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 57
Data table 48: Pharmaceutical and Healthcare, Global, Top Private Equity Deals, 2010 58
Data table 49: Pharmaceutical and Healthcare, Global, Private Equity Deals, by Therapy Area, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), 2010 59
Data table 50: Pharmaceutical and Healthcare, Global, Venture Capital, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 60
Data table 51: Pharmaceutical and Healthcare, Global, Venture Capital, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 61
Data table 52: Pharmaceutical and Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), 2010 62
Data table 53: Pharmaceutical and Healthcare, Global, Venture Capital Deals, by Therapy Area, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), 2010 63
Data table 54: Pharmaceutical and Healthcare, Global, Top VC Backed Firms, Q1 2010 - Q4 2010 64
Data table 55: Pharmaceutical and Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$m), 2010 65
Data table 56: Pharmaceutical and Healthcare, Top Venture Financing Deals, Global, 2010 66
Data table 57: Pharmaceutical and Healthcare, Global, Oncology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 68
Data table 58: Pharmaceutical and Healthcare, Global, Oncology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 70
Data table 59: Pharmaceutical and Healthcare, Global, Central Nervous System, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 72
Data table 60: Pharmaceutical and Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 73
Data table 61: Pharmaceutical and Healthcare, Global, Infectious Disease, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 75
Data table 62: Pharmaceutical and Healthcare, Global, Infectious Disease, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 76
Data table 63: Pharmaceutical and Healthcare, Global, Immunology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 78
Data table 64: Pharmaceutical and Healthcare, Global, Immunology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 80
Data table 65: Pharmaceutical and Healthcare, Global, Cardiovascular, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 81
Data table 66: Pharmaceutical and Healthcare, Global, Cardiovascular, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 83
Data table 67: Pharmaceutical and Healthcare, Global, Metabolic Disorders, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 84
Data table 68: Pharmaceutical and Healthcare, Global, Metabolic Disorders, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 86
Data table 69: Pharmaceutical and Healthcare, Global, Dermatology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 88
Data table 70: Pharmaceutical and Healthcare, Global, Dermatology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 90
Data table 71: Pharmaceutical and Healthcare, North America, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 92
Data table 72: Pharmaceutical and Healthcare, North America, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 94
Data table 73: Pharmaceutical and Healthcare, Europe, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 95
Data table 74: Pharmaceutical and Healthcare, European Region Deals, Merger and Acquisition Deal Summary, Global, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 97
Data table 75: Pharmaceutical and Healthcare, Asia-Pacific, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 98
Data table 76: Pharmaceutical and Healthcare, Asia-Pacific Region Deals, Merger and Acquisition Deal Summary, Global, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 100
Data table 77: Pharmaceutical and Healthcare, Rest of the World Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), from 2006 to 2010 101
Data table 78: Pharmaceutical and Healthcare, Rest of the World Deals, Merger and Acquisition Deal Summary, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 103
Data table 79: Pharmaceutical and Healthcare, Global,, Top Financial Advisors, Merger and Acquisition, Number of Deals and Deal Value (US$m), 2010 104
Data table 80: Pharmaceutical and Healthcare, World Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$m), 2010 105

1.2 List of Charts
Chart 1: Pharmaceutical and Healthcare, Global, Number of Deals and Deal Value (US$m), from 2006 to 2010 9
Chart 2: Pharmaceutical and Healthcare, Global, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 11
Chart 3: Pharmaceutical and healthcare, Global, Number Of Deals (%) and Deal Values (%), 2010 13
Chart 4 Pharmaceutical and Healthcare, Global, Merger and Acquisition, Number of Deals and Deal Values (US$m), from 2006 to 2010 18
Chart 5 Pharmaceutical and Healthcare, Global, Merger and Acquisition, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 19
Chart 6: Pharmaceutical and Healthcare, Global, Merger and Acquisition s, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, 2010 21
Chart 7: Pharmaceutical and Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$m), from 2006 to 2010 22
Chart 8: Pharmaceutical and Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 23
Chart 9: Pharmaceutical and Healthcare, Global, IPO Deals, Number of Deals and Deal Value (US$m), from 2006 to 2010 24
Chart 10: Pharmaceutical and Healthcare, Global, Secondary Offerings Deals, Number of Deals and Deal Value (US$m), from 2006 to 2010 26
Chart 11: Pharmaceutical and Healthcare, Global, PIPE Deals, Number of Deals and Deal Value (US$m), from 2006 to 2010 28
Chart 12: Pharmaceutical and Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), 2010 30
Chart 13: Pharmaceutical and Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$m), from 2006 to 2010 31
Chart 14: Pharmaceutical and Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 32
Chart 15: Pharmaceutical and Healthcare, Global, Public Debt Offerings Deals, Number of Deals and Deal Value (US$m), from 2006 to 2010 33
Chart 16: Pharmaceutical and Healthcare, Global, Private Debt Placements, Number of Deals and Deal Value (US$m), from 2006 to 2010 34
Chart 17: Pharmaceutical and Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), 2010 36
Chart 18: Pharmaceutical and Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$m), from 2006 to 2010 37
Chart 19: Pharmaceutical and Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 38
Chart 20: Pharmaceutical and Healthcare, Global, Partnership Deals Break-Up (%), 2010 39
Chart 21: Pharmaceutical and Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$m), 2010 40
Chart 22: Pharmaceutical and Healthcare, Global, Partnership Deals, Upfront and Milestone Payment and Deal Values (US$m), 2010 41
Chart 23: Pharmaceutical and Healthcare, Global, Partnership Deals, by Therapy Area, Upfront and Milestone Payment and Deal Values (US$m), 2010 42
Chart 24: Pharmaceutical and Healthcare, Global, Partnership Deals, by Phase, 2010 43
Chart 25: Pharmaceutical and Healthcare, Global, Partnership Deals, by Phase, by Upfront and Milestone Payments and Deal Values (US$m), 2010 44
Chart 26: Pharmaceutical and Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$m), from 2006 to 2010 47
Chart 27: Pharmaceutical and Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 48
Chart 28: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$m), 2010 49
Chart 29: Pharmaceutical and Healthcare, Global, Licensing Agreements, Upfront and Milestone Payments and Deal Values (US$m), 2010 50
Chart 30: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront and Milestone Payment and Deal Values (US$m), 2010 51
Chart 31: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Phase, 2010 52
Chart 32: Pharmaceutical and Healthcare, Global, Licensing Agreements, by Phase, by Upfront and Milestone Payment and Deal Values (US$m), 2010 53
Chart 33: Pharmaceutical and Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$m), from 2006 to 2010 56
Chart 34: Pharmaceutical and Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 57
Chart 35: Pharmaceutical and Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, 2010 59
Chart 36: Pharmaceutical and Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$m), from 2006 to 2010 60
Chart 37: Pharmaceutical and Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 61
Chart 38: Pharmaceutical and Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%) and Deal Values (%), 2010 62
Chart 39: Pharmaceutical and Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, 2010 63
Chart 40: Pharmaceutical and Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$m), 2010 65
Chart 41: Pharmaceutical and Healthcare, Global, Oncology, Number of Deals and Deal Values (US$m), from 2006 to 2010 67
Chart 42: Pharmaceutical and Healthcare, Global, Oncology, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 69
Chart 43: Pharmaceutical and Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$m), 2010, from 2006 to 2010 71
Chart 44: Pharmaceutical and Healthcare, Central Nervous System, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 73
Chart 45: Pharmaceutical and Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$m), from 2006 to 2010 75
Chart 46: Pharmaceutical and Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 76
Chart 47: Pharmaceutical and Healthcare, Global, Immunology, Number of Deals and Deal Values (US$m), from 2006 to 2010 78
Chart 48: Pharmaceutical and Healthcare, Global, Immunology, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 79
Chart 49: Pharmaceutical and Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$m), from 2006 to 2010 81
Chart 50: Pharmaceutical and Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 82
Chart 51: Pharmaceutical and Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$m), from 2006 to 2010 84
Chart 52: Pharmaceutical and Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 85
Chart 53: Pharmaceutical and Healthcare, Global, Dermatology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), from 2006 to 2010 87
Chart 54: Pharmaceutical and Healthcare, Global, Dermatology, Merger and Acquisition Deal Summary, Number of Deals and Deal Values (US$m), Q1 2010-Q4 2010 89
Chart 55: Pharmaceutical and Healthcare, North America, Number of Deals and Deal Value (US$m), from 2006 to 2010 91
Chart 56: Pharmaceutical and Healthcare, North America, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 93
Chart 57: Pharmaceutical and Healthcare, Europe, Number of Deals and Deal Value (US$m), from 2006 to 2010 95
Chart 58: Pharmaceutical and Healthcare, Europe, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 96
Chart 59: Pharmaceutical and Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$m), from 2006 to 2010 98
Chart 60: Pharmaceutical and Healthcare, Asia-Pacific Region, Deals, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 99
Chart 61: Pharmaceutical and Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$m), from 2006 to 2010 101
Chart 62: Pharmaceutical and Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$m), Q1 2010-Q4 2010 102
Chart 63: Pharmaceutical and Healthcare, Global, Top Financial Advisors, Merger and Acquisition, Number of Deals and Deal Value (US$m), 2010 104
Chart 64: Pharmaceutical and Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$m), 2010 105

Companies Mentioned

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Adalimumab  - Comprehensive patent search

Adalimumab - Comprehensive patent search

  • $ 10 118
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world's leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Amphotericin B  - Comprehensive patent search

Amphotericin B - Comprehensive patent search

  • $ 10 118
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world's leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Bemiparin sodium  - Comprehensive patent search

Bemiparin sodium - Comprehensive patent search

  • $ 10 118
  • Company report
  • August 2014
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world's leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.